Last €2.83 EUR
Change Today +0.06 / 2.17%
Volume 0.0
AAQ On Other Exchanges
As of 2:16 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

aap implantate (AAQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/3/14 - €3.65
52 Week Low
10/1/13 - €1.23
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AAP IMPLANTATE (AAQ)

Related News

No related news articles were found.

aap implantate (AAQ) Related Businessweek News

No Related Businessweek News Found

aap implantate (AAQ) Details

aap Implantate AG, a medical device company, researches, develops, manufactures, and sells implants, medical instruments, bone cements, and replacement materials for use in orthopedic procedures in Germany and internationally. It provides LOQTEQ, an anatomical angular stable plating system for compressing fractures with angular stable locking screws; and fragment set comprising T, L, quarter tubular, and reconstruction plates, as well as cortical and cancellous screws. It also offers cannulated screws for the treatment of hand and foot fracture; AcroPlate, which is used for the treatment of AC joint injuries; and autodynamic plating systems for secure fracture stabilization. In addition, the company provides a range of bone cements and accessories for application in arthroplasty, vertebroplasty, and kyphoplasty; and collagen fleeces for ambulant and stationary tissue care. Further, it offers bone substitutes that includes Artosal, a synthetic osteoconductive bone substitute; Cerabone, a ceramic bone substitute; OsteoCem, a calcium phosphate cement; Osnatal, a human bone allograft; and PerOssal, a synthetic bone substitute and carrier material. The company sells its products through its direct sales force, and distribution partners, as well as through license agreements with OEM partners. aap Implantate AG is headquartered in Berlin, Germany.

199 Employees
Last Reported Date: 05/16/14

aap implantate (AAQ) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €381.0K
Chief Finance Officer and Member of the Manag...
Total Annual Compensation: €260.0K
Compensation as of Fiscal Year 2013.

aap implantate (AAQ) Key Developments

AAP Implantate AG Announces Earnings Results for the Second Quarter and First Half Year of 2014

AAP Implantate AG announced earnings results for the second quarter and first half year of 2014. For the quarter, the company reported sales of EUR 8.1 million compared to EUR 6.6 million a year ago. EBITDA was EUR 1.5 million compared to EUR 0.2 million a year ago. EBIT was EUR 1.0 million compared to LBIT of EUR 0.3 million a year ago. The group achieved sales growth to EUR 14.2 million in the first half of 2014 compared to EUR 12.6 million a year ago. EBITDA was EUR 1.6 million compared to EUR 2.6 million.

AAP Implantate AG, Q2 2014 Earnings Call, Aug 14, 2014

AAP Implantate AG, Q2 2014 Earnings Call, Aug 14, 2014

AAP Implantate AG Reports Sales Results for the Second Quarter and Six Months of 2014

AAP Implantate AG reported sales results for the second quarter and six months of 2014. For the quarter, the company reported sales from continued operations of EUR 8.0 million against EUR 6.6 million a year ago. For the six months, the company reported sales from continued operations of EUR 14.2 million against EUR 12.6 million a year ago. Total sales were EUR 15.2 million against EUR 19.6 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AAQ:GR €2.83 EUR +0.06

AAQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AAQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation AAQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.9x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAP IMPLANTATE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at